Full Press Release Details
Ultragenyx to Present at the 42nd Annual J.P. Morgan Healthcare Conference.
RARE
Ultragenyx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Key Takeaway: Ultragenyx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Price reaction · baseline $47.82 (2023-12-29 close) · hit after-hours · 2 other RARE headline(s) in the window, move may be shared
day 0 close
+0.7%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+43%
120-day peak, hindsight
Typical move
2.9%
average across 6 past catalysts
Cash runway
~13 mo
Low dilution risk
Lead asset
BPS804
Phase 2 · Hypophosphatasia